Candesartan HCT Zentiva 8/12.5mg, Tabletten - 30 Swissmedic Key 62321013 Registration Holder Helvepharm AG Name Candesartan HCT Zentiva 8/12.5mg, Tabletten Date of registration 30.01.2012 Original/Generic Generic Introduction of Sequence 30.01.2012 ATC-Classification Candesartan and Diuretics (C09DA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.20. Show package size 30 Index Therapeuticus (Swissmedic) 02.07.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 8.23 Limitation No Deductible 10 % Consumer price 18.15 Feedback FB GTIN 7680623210135 Medication Code Synthetika Pharmacode Disponibility
Composition candesartanum cilexetilum 8 mg, hydrochlorothiazidum 12.5 mg, maydis amylum, lactosum monohydricum 117.3 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.36 mg, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 8 mg Hydrochlorothiazide 12.5 mg
BAG: Active Agent Dose Candesartanum Cilexetil 8 mg Hydrochlorothiazide 12.5 mg
Inactive agents Dose Lactose Monohydrate 117.3 mg
Source Data was imported : 11.07.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
